Neovascular Age-Related Macular Degeneration
nAMD and DME Management: Game-Changing Sustained Delivery Platforms
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
European Commission approves Opuviz as aflibercept biosimilar
The European Commission has approved Opuviz 40 mg/mL solution, a biosimilar referencing Eylea, according to a press release from Samsung Bioepis and Biogen.
AlloVir to merge with Kalaris Therapeutics
AlloVir, an allogeneic T cell immunotherapy company, will merge with Kalaris Therapeutics to focus on retinal diseases, according to a press release.
VIDEO: Bilateral ABBV-RGX-314 shows positive outcomes in wet AMD
CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Arshad M. Khanani, MD, MA, FASRS, discusses bilateral ABBV-RGX-314 gene therapy for neovascular age-related macular degeneration.
VIDEO: Sozinibercept combination therapy in PCV results in marked visual acuity gain
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Gemmy Cheung, MD, PhD, expresses satisfaction with the effects of sozinibercept in patients with polypoidal choroidal vasculopathy, or PCV.
The Retina Radar With Dr. Arshad Khanani on DR, GA, New Mechanisms, and Noninvasive Treatments
This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; AbbVie Inc.; Astellas; Apellis Pharmaceuticals, Inc.; Opthea; Alimera Sciences, Inc.; EyePoint Pharmaceuticals, Inc.; Neurotech Pharmaceuticals, Inc.; REGENXBIO Inc.; and Ocular Therapeutix, Inc.
UK-based real-world study shows effective, long-lasting outcomes of faricimab in DME
BARCELONA, Spain — A large amount of real-world data collected from clinics across the U.K. highlighted the effectiveness, safety and durability of faricimab for diabetic macular edema in treatment-naive and previously treated eyes.
In Case You Missed…Translating the Latest Clinical Trial Insights Into Retinal Disease Management
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
VIDEO: Sozinibercept combination therapy shows promising visual acuity gains in wet AMD
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Timothy L. Jackson, PhD, MBChB, discusses phase 2b trial results of sozinibercept for neovascular age-related macular degeneration.
Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C & D
This activity is supported by an educational grant from Opthea.